World's Best Scientists 2026 revealed!
Jacques Lespérance

Jacques Lespérance

D-Index & Metrics

Medicine

D-Index
71
Citations
18543
World Ranking
19991
National Ranking
840

Overview

Jacques Lespérance is affiliated with the Montreal Heart Institute in Canada and has contributed to research primarily in the field of Medicine. Their work spans multiple subfields including Pulmonary and Respiratory Medicine, Emergency Medical Services, Nephrology, Epidemiology, and Cardiology and Cardiovascular Medicine.

Their research covers several main topics, reflecting a focus on clinical and procedural aspects within cardiovascular and renal health. These topics include:

  • Central Venous Catheters and Hemodialysis
  • Vascular Procedures and Complications
  • Acute Kidney Injury Research
  • Congenital Heart Disease Studies
  • Cardiac Valve Diseases and Treatments
  • Coronary Artery Anomalies

Lespérance's recent publications showcase contributions to vascular and cardiac research. Notable papers include:

  • Safety and Efficacy of Paclitaxel-Eluting Balloon Angioplasty for Dysfunctional Hemodialysis Access: A randomized trial Comparing with Angioplasty Alone, published in 2021 in the Journal of Vascular and Interventional Radiology
  • A forme fruste of Shone's anomaly in a 65 year-old patient, published in 2020 in the McGill Journal of Medicine

Frequent collaborators found in their work include Éric Thérasse, Véronique Caty, Patrick Gilbert, Marie-France Giroux, and Pierre Perreault.

The scientist has published in journals such as the Journal of Vascular and Interventional Radiology and the McGill Journal of Medicine, among others, indicating a focus on clinical interventional techniques and case studies.

Best Publications

  • Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

    Leonard Schwartz;Martial G. Bourassa;Jacques Lespérance;Harold E. Aldridge

  • Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.

    J C Tardif;G Cöté;J Lespérance;M Bourassa

  • The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

    Lucien Campeau;Marc Enjalbert;Jacques Lespérance;Martial G. Bourassa

  • Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation.

    C M Grondin;L Campeau;J Lesperance;M Enjalbert

  • Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

    Jean-Claude Tardif;Jean Grégoire;Philippe L. L’Allier;Reda Ibrahim

  • Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries.

    B R Chaitman;J Lespérance;J Saltiel;M G Bourassa

  • Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery.

    Campeau L;Enjalbert M;Lespérance J;Vaislic C

  • A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

    D Waters;J Lespérance;M Francetich;D Causey

  • Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization

    Claude M. Grondin;Ihor Dyrda;André Pasternac;Lucien Campeau

  • Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.

    M G Bourassa;L D Fisher;L Campeau;M J Gillespie

  • Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies.

    Martial G Bourassa;Ady Butnaru;Jacques Lespérance;Jean-Claude Tardif

  • Prognostic significance of progression of coronary atherosclerosis.

    D Waters;T E Craven;J Lespérance

  • Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS)

    Lloyd D. Fisher;Melvin P. Judkins;Jacques Lesperance;Airlie Cameron

  • Unstable angina and progression of coronary atherosclerosis.

    Alain Moise;Pierre Théroux;Yves Taeymans;Bénédicte Descoings

  • Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries.

    L Campeau;J Lespérance;J Hermann;F Corbara

  • Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions

    Jean-Claude Tardif;Jean Grégoire;Philippe L. L’Allier;Todd J. Anderson

  • Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later.

    Martial G. Bourassa;Marc Enjalbert;Lucien Campeau;Jacques Lesperance

  • Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity

    B.Charles Solymoss;Martial G Bourassa;Lucien Campeau;Allan Sniderman

  • Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions

    Jean-Claude Tardif;Jean Grégoire;Leonard Schwartz;Lawrence Title

  • Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

    Jean-Claude Tardif;Jean-Claude Tardif;Christie M. Ballantyne;Philip Barter;Jean-Louis Dasseux

Frequent Co-Authors

Martial G. Bourassa
Martial G. Bourassa Montreal Heart Institute
Jean-Claude Tardif
Jean-Claude Tardif Montreal Heart Institute
Pierre Théroux
Pierre Théroux Montreal Heart Institute
Jean Meunier
Jean Meunier University of Montreal
Colin Berry
Colin Berry University of Glasgow
David D. Waters
David D. Waters University of California, San Francisco
Richard L. Gallo
Richard L. Gallo University of California, San Diego
Lloyd D. Fisher
Lloyd D. Fisher University of Washington
Stanley Nattel
Stanley Nattel Montreal Heart Institute
Thomas J. Ryan
Thomas J. Ryan Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not ready to commit to medical school, there are several rewarding, alternative pathways available online. Many students start by exploring adn nursing programs, which offer a quicker route to becoming a registered nurse. These programs typically have fewer prerequisites and can open doors to various clinical roles.

Another in-demand field is medical billing and coding. Flexible options like medical billing and coding schools that accept financial aid make it easier for students from different backgrounds to begin a healthcare career focused on the administrative and technical side.

If you’re wondering about exam requirements, not all nursing tracks are the same. Certain programs let you become a Licensed Practical Nurse without extensive standardized testing; you can learn more about alternatives in do i need to take the teas test for lpn.

Those aiming for leadership roles may prefer a healthcare administration associate degree online, which focuses on the business side of medicine. These accessible degree options can accelerate your entry into healthcare, allowing for diverse career growth.

Best Scientists Citing Jacques Lespérance

Trending Scientists